Sara Lauria

Title: Sara Lauria: Innovator in Pharmaceutical Formulations

Introduction

Sara Lauria is a prominent inventor based in Monzo, Italy. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on platinum derivatives. With a total of 2 patents, her work is paving the way for advancements in antitumor therapies.

Latest Patents

Sara Lauria's latest patents include innovative formulations that enhance the stability and effectiveness of oxaliplatin. The first patent describes novel stable solution formulations comprising oxaliplatin alone or in combination with irinotecan (CPT-11), along with an effective stabilizing amount of lactic acid and/or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. This invention also outlines a method for manufacturing such formulations ready for administration, emphasizing their use in antitumor therapy. The second patent similarly focuses on stable solution formulations of oxaliplatin, highlighting the importance of lactic acid and its salts in enhancing the pharmaceutical properties of the drug.

Career Highlights

Sara Lauria is currently associated with Pharmacia Italia S.p.a., where she continues to innovate in the pharmaceutical sector. Her expertise in developing stable formulations has positioned her as a key player in the industry, contributing to the advancement of cancer treatment options.

Collaborations

Sara collaborates with talented professionals such as Alessandro Martini and Cristina Ciocca, who share her commitment to improving pharmaceutical formulations. Their teamwork fosters an environment of innovation and excellence in research.

Conclusion

Sara Lauria's contributions to pharmaceutical formulations, particularly in the realm of platinum derivatives, demonstrate her dedication to advancing medical science. Her innovative patents and collaborative efforts are making a significant impact in the fight against cancer.